Beutel, Goodman & Company »

iShares NASDAQ Biotechnology Index shares owned by Beutel, Goodman & Company

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Beutel, Goodman & Company from 13F filings

Historical chart of Beutel, Goodman & Company investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Beutel, Goodman & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Beutel, Goodman & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0k 45 133.33
2025-06-30 $5.0k 45 111.11
2025-03-31 $5.0k 45 111.11

More positions owned by Beutel, Goodman & Company

Toronto Dominion Bk Common (TD)
Bank of Montreal Common (BMO)
Royal Bank Cda Adr (2 Ord) (RY)
Medtronic Common (MDT)
Qualcomm Common (QCOM)
NetApp Common (NTAP)
Chubb Common (CB)
Amgen Common (AMGN)
American Express Common (AXP)
Merck& Co Common (MRK)
PPG Industries Common (PPG)
Gen Digital Common (GEN)
Cdn Natl Railway Common (CNI)
Amdocs Ordinary (DOX)
Comcast Corp Common (CMCSA)

View all positions for Beutel, Goodman & Company

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index